期刊文献+

甲型流感病毒(H1N2)亚型毒株血凝素和神经氨酸酶基因来源的研究 被引量:2

Study on the origin of influenza A(H1N2) virus HA and NA genes
原文传递
导出
摘要 目的 研究新分离到的H1N2亚型毒株血凝素 (HA)和神经氨酸酶 (NA)基因的来源。方法 病毒通过鸡胚增殖后提取其RNA ,通过逆转录合成cDNA ,经PCR扩增和产物纯化 ,用双脱氧链终止法进行核苷酸序列测定 ,并用MegAlign(1 0 3版 )和Editseq(3 6 9版 )软件进行种系发生学分析。结果 新分离到H1N2毒株HA1区氨基酸序列与A/PR/ 8/ 34 (H1N1)和A/Guangdong/ 6 / 91(H1N1)毒株间的同源性分别为 98 2 %和 99 4% ;NA蛋白分子氨基酸序列与 1995年的甲 3(H3N2 )亚型毒株间同源性高达 99 1%。结论 新分离的H1N2毒株是A/PR/ 8/ 34 (H1N1)类毒株与甲 3(H3N2 )亚型毒株通过基因重配而来。 Objective To determine the origins of the HA and NA genes of new subtype (H1N2) of influenza A virus. Methods Virus was amplified in embryonated chicken eggs, then virion RNA was transcribed into cDNA by reverse transcriptase, cDNA amplified by PCR, the products of PCR were purified. Afterward, RNA sequence analysis was performed by the dideoxynucleotide chain termination method, using synthetic oligodideoxynucleotide primers. Finally, phylogenetic analysis of the sequencing data was performed with MegAlign (Version 1 03) and Editseq (Version 3 69) softwares. Results The homology of amino acid sequences of protein molecules on HA1 domains when compared, with A/PR/8/34(H1N1) and A/Guangdong/6/91(H1N1) viruses was 98 2% and 99 4%, respectively. The homology of amino acid sequences of NA protein molecules between the novel reassortant and H1N1 virus was only 83 4%, but the homology of those between H1N2 strain and H3N2 virus circulating in men in 1995 was as high as 99 1%. Conclusion The new reassortant(H1N2) virus HA gene was derived from A/PR/8/34(H1N1) like virus, but its NA gene was derived from H3N2 virus circulating in men in 1995.
出处 《中华实验和临床病毒学杂志》 CSCD 2000年第1期34-39,共6页 Chinese Journal of Experimental and Clinical Virology
基金 国家自然科学基金! ( 3 9770 0 3 8)
关键词 正粘病毒A型 血凝素 神经氨酸酶 基因 Influenza A virus human Haemagglutinin Neuraminidase Genes
  • 相关文献

参考文献5

二级参考文献9

共引文献9

同被引文献15

  • 1陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 2卫生部.全国流感监测方案(2010年版)[EB].2010,9.
  • 3Shu YL, Fang LQ, Sake J, et al. Dual seasonal patterns for influenza, China. Emerg Infect Dis, 2010,16(4):725-726.
  • 4Schweiger B, Zadow I, Heckler R. Antigenic drift and variability of influenza viruses 2002,191(3):133-138.
  • 5中华人民共和国卫生部.甲型H1N1流感诊疗方案@009年第3版)[s].2009:1-5.
  • 6World Health Organization.WHO surveillance case definitions for ILI and SARI [EB/OL]. http://www.who.int/influenza/surveillance_mon- itoring/ili_sari_surveillance case definition/en/,2015-07-02.
  • 7Houser K, Subbarao K.Influenza vaccines: challenges andsolutions [J]. Cell Host Microbe, 2015,17(3):295-300.
  • 8King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-ba- sed influenza vaccination[J]. N Engl J Med, 2006,355(24):2523- 2532.
  • 9曹彬,李冉,刘颖梅,曹志新,耿秀琴,刘乐庭,卢洁,巫琳,崔树峰,白瑞婷,于常海,王辰.流感样疾病的病原学与治疗及预后的关系[J].中华结核和呼吸杂志,2008,31(7):483-487. 被引量:9
  • 10舒跃龙.流感监测的发展历史及思考[J].中华流行病学杂志,2011,32(4):334-336. 被引量:100

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部